PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

78 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
Winter, B.* et al.: NR4A2 and dystonia with dopa responsiveness. Mov. Disord. 36, 2203-2204 (2021)
42.
Zech, M. et al.: Scoring algorithm-based genomic testing in dystonia: A prospective validation study. Mov. Disord. 36, 959-1964 (2021)
43.
Zech, M. et al.: A neurodevelopmental disorder with dystonia and chorea resulting from clustering CAMK4 variants. Mov. Disord. 36, 520-521 (2021)
44.
Zech, M. et al.: Biallelic AOPEP loss-of-function variants cause progressive dystonia with prominent limb involvement. Mov. Disord., DOI: 10.1002/mds.28804 (2021)
45.
Hopfner, F.* et al.: Rare variants in specific lysosomal genes are associated with Parkinson's disease. Mov. Disord. 35, 1245-1248 (2020)
46.
Kishore, A.* et al.: Understanding the role of genetic variability in LRRK2 in Indian population. Mov. Disord. 34, 496-505 (2019)
47.
Kübler, D.* et al.: Widespread microglial activation in multiple system atrophy. Mov. Disord. 34, 564-568 (2019)
48.
Salminen, A.V. et al.: Reply to: A note on rotigotine for restless legs syndrome after renal transplantation. Mov. Disord. 34, 152-153 (2019)
49.
Salminen, A.V. et al.: Reply to: Safety of dopamine agonists for treating restless legs syndrome. Mov. Disord. 34, 150-151 (2019)
50.
Riedhammer, K.M.* ; Leszinski, G.S.* ; Andres, S. ; Strobl-Wildemann, G.* & Wagner, M.: First replication that biallelic variants in FITM2 cause a complex deafness-dystonia syndrome. Mov. Disord. 33, 1665-1666 (2018)
51.
Winkelmann, J. et al.: Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§. Mov. Disord. 33, 1077-1091 (2018)
52.
Meles, S.K.* et al.: FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder. Mov. Disord. 32, 1482-1486 (2017)
53.
Trenkwalder, C.* et al.: Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial. Mov. Disord. 32, 1478-1482 (2017)
54.
Vill, K.* et al.: A homozygous splice variant in AP4S1 mimicking neurodegeneration with brain iron accumulation. Mov. Disord. 32, 797-799 (2017)
55.
Zech, M. et al.: KMT2B rare missense variants in generalized dystonia. Mov. Disord. 32, 1087-1091 (2017)
56.
Jochim, A.* ; Zech, M. ; Gora-Stahlberg, G.* ; Winkelmann, J. & Haslinger, B.*: The clinical phenotype of early-onset isolated dystonia caused by recessive COL6A3 mutations (DYT27). Mov. Disord. 31, 747-750 (2016)
57.
Zech, M. et al.: Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up. Mov. Disord. 32, 549-559 (2016)
58.
Nalls, M.A.* et al.: Genetic risk and age in Parkinson's disease: Continuum not stratum. Mov. Disord. 30, 850-854 (2015)
59.
Witoelar, A.W.* et al.: Genome wide pleiotropic study in 144,701 subjects reveals shared genetic variants between Parkinson's disease and immune-mediated diseases. Mov. Disord. 30, S412 (2015)
60.
Zech, M. ; Castrop, F.* ; Haslinger, B.* & Winkelmann, J.: Reply to letter: Novel compound heterozygous mutations in PRKRA cause pure dystonia. Mov. Disord. 30, 878–879 (2015)